Table 2. Diagnostic accuracies of APRI and FIB-4 for predicting liver fibrosis (all patients, N = 1716).
Index | AUROCcutoff | cutoff | sensitivitycutoff | specificitycutoff | PPVcutoff | NPVcutoff | Sensitivity + Specificity-1 |
---|---|---|---|---|---|---|---|
To predict fibrosis ≥2 | |||||||
APRI | 0.68 (0.66–0.70) | 1.4 | 72.4% | 63.2% | 68.9% | 67.1% | 35.6% |
FIB-4 | 0.70 (0.68–0.72) | 2.9 | 62.7% | 78.0% | 76.2% | 65.0% | 40.6% |
To predict fibrosis ≥3 | |||||||
APRI | 0.68 (0.66–0.70) | 1.6 | 67.1% | 68.8% | 62.3% | 62.3% | 36.6% |
FIB-4 | 0.73 (0.71–0.75) | 2.9 | 69.1% | 76.1% | 68.9% | 76.3% | 45.2% |
To predict fibrosis = 4 | |||||||
APRI | 0.70 (0.68–0.73) | 2.2 | 64.9% | 75.4% | 47.3% | 86.3% | 40.3% |
FIB-4 | 0.73 (0.70–0.75) | 3.1 | 72.0% | 73.4% | 47.9% | 88.5% | 46.6% |
APRI, aspartate aminotransferase (AST)- to-platelet ratio index; FIB-4, fibrosis index based on the four factors; AUROC, area under receiver operating characteristic